Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of TM471-1 capsules in relapsed or refractory marginal zone lymphoma
CTR20261321Phase 2Active
- Sponsor
- Zhiwei Biopharma
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TM471-1 in marginal zone B-cell lymphoma (MZL), sponsored by Zhiwei Biopharma. Started Apr 2026; status: active.
02
Drugs
TM471-1
03
Conditions
marginal zone B-cell lymphoma (MZL)
Beyond the preview
Go deeper on CTR20261321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261321.